Your browser doesn't support javascript.
loading
The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
Johal, Kirti J; Chichester, Kristin L; Oliver, Eric T; Devine, Kelly C; Bieneman, Anja P; Schroeder, John T; MacGlashan, Donald W; Saini, Sarbjit S.
Afiliación
  • Johal KJ; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md; Division of Allergy and Immunology, Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Chichester KL; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
  • Oliver ET; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
  • Devine KC; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
  • Bieneman AP; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
  • Schroeder JT; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
  • MacGlashan DW; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
  • Saini SS; Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: ssaini@jhmi.edu.
J Allergy Clin Immunol ; 147(6): 2271-2280.e8, 2021 06.
Article en En | MEDLINE | ID: mdl-33713769
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Basófilos / Antialérgicos / Omalizumab / Urticaria Crónica Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Allergy Clin Immunol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Basófilos / Antialérgicos / Omalizumab / Urticaria Crónica Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Allergy Clin Immunol Año: 2021 Tipo del documento: Article